Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 11, 2021

SELL
$27.5 - $37.92 $522 - $720
-19 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$34.44 - $43.75 $654 - $831
19 New
19 $1,000
Q2 2020

Aug 14, 2020

SELL
$27.12 - $45.97 $894 - $1,517
-33 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$26.16 - $63.5 $863 - $2,095
33 New
33 $2,000

Others Institutions Holding BLUE

About bluebird bio, Inc.


  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $25.5M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Associated Banc Corp Portfolio

Follow Associated Banc Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Associated Banc Corp, based on Form 13F filings with the SEC.

News

Stay updated on Associated Banc Corp with notifications on news.